Assessing the Preparedness of the U.S. Health Care System Infrastructure for an Alzheimer's Treatment
The DOI matches its Crossref record; 8 of the 9 references it cites were found in a registry or an index.
Abstract
Promising early-stage trial results provide hope that a therapy for Alzheimer's disease may become available that can prevent progression to full-blown dementia. But an important challenge will arise: A substantial backlog of existing cases with early-stage disease would have to be screened, diagnosed, and then potentially treated. This report assesses the preparedness of the U.S. health care system to handle the potential caseload.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anticipating the development and approval of aducanumab (or a similar therapy), a 2017 simulation by RAND Corporation researchers found that”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [655]
In the citing paper
“As with the earlier discussion on barriers to diagnosis, this simulation highlights how workforce shortages can directly impact individuals' health outcomes and underscores the need to expand the workforce to meet existing and future demand.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [655]
In the citing paper
“The researchers projected an average wait time of 18.6 months between diagnosis and treatment once the new drug was approved.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [655]
In the citing paper
“Capacity constraints -such as a limited number of qualified providers and facilities -could severely restrict access to new treatments.655,806”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [655]
In the citing paper
“modeling by the RAND Corporation in 2017 showed that with an anti‐amyloid therapy for people in the MCI and early dementia stages of the disease, approximately 2.1 million individuals with MCI due to Alzheimer's disease would develop Alzheimer's dementia between 2020 and 2040 while on waiting lists for treatment.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [972]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642
Sachdev, P. S., Lipnicki, D. M., Kochan, N. A., Crawford, J. D., Thalamuthu, A., Andrews, G., Brayne, C., Matthews, F. E., Stephan, B. C. M., Lipton, R. B., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142388 · Cited by 380
Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
Folch, J., Petrov, D., Ettcheto, M., Abad, S., Sánchez-López, E., García, M. L., Olloquequi, J., Beas-Zarate, C., Auladell, C., & Camins, A. (2016) · Neural Plasticity · doi:10.1155/2016/8501693 · Cited by 270 · cited 1×
“While the exact pathobiology is not fully understood, those plaques are associated with degeneration of neurons, leading to dementia (Folch et al., 2016).”
BackgroundEconomic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches
Buck, A. K., Herrmann, K., Stargardt, T., Dechow, T., Krause, B. J., & Schreyogg, J. (2010) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.108.059584 · Cited by 107
Supply and demand analysis of the current and future US neurology workforce
Racette, B. A., & Holtzman, D. M. (2014) · Neurology · doi:10.1212/wnl.0000000000000509 · Cited by 28
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
Harnois, D. M. (2011) · Yearbook of Gastroenterology · doi:10.1016/j.ygas.2011.07.083 · Cited by 19
(2017) · Springer Publishing Company eBooks · doi:10.1891/9780826150349.0017 · Cited by 14
The Workforce Task Force Report: Clinical implications for neurology
Hodgson, T. S., & Lukas, R. V. (2014) · Neurology · doi:10.1212/wnl.0000000000000161 · Cited by 9
Cited by
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2021 Alzheimer's disease facts and figures
(2021) · Alzheimer's & Dementia · doi:10.1002/alz.12328 · Cited by 2,201
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
“health care system to care for people with Alzheimer’s disease or related dementias in the upcoming decades [401].”
Metadata
- Authors
- Liu, J., Hlavka, J., Hillestad, R., & Mattke, S.
- Venue
- RAND Corporation eBooks
- Publisher
- RAND Corporation
- Published
- 2017
- OpenAlex
- W2770679810
- Cited by
- 98
- References
- 9
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 13 · 2023: 12 · 2022: 15 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 4 · 2017: 1
- FWCI
- 11.87
- Type
- book
- Language
- en
- Open access
- closed
- Locations
- RAND Corporation eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- Alzheimer's disease, health system preparedness, health infrastructure, early Alzheimer's disease, dementia prevention, screening and diagnosis, health care capacity, health policy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessing the Preparedness of the U.S. Health Care System Infrastructure for an Alzheimer's Treatment. https://app.cochat.ai/papers/10.7249/rr2272
- The paper
- Liu, J., Hlavka, J., Hillestad, R., & Mattke, S. (2017). Assessing the Preparedness of the U.S. Health Care System Infrastructure for an Alzheimer's Treatment. RAND Corporation eBooks. https://doi.org/10.7249/rr2272
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.